AI Verdict
HCA has stronger fundamentals based on our AI analysis.
ABBV vs HCA Fundamental Comparison
| Metric | ABBV | HCA |
|---|---|---|
| Revenue | $61.2B | $75.6B |
| Net Income | $4.2B | $6.8B |
| Net Margin | 6.9% | 9.0% |
| ROE | N/A | N/A |
| ROA | 3.2% | 11.2% |
| Current Ratio | 0.67x | 0.97x |
| Debt/Equity | N/A | N/A |
| EPS | $2.36 | $28.33 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs HCA: Frequently Asked Questions
Is ABBV or HCA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HCA has stronger fundamentals. ABBV is rated HOLD (70% confidence) while HCA is rated BUY (75% confidence). This is not investment advice.
How does ABBV compare to HCA fundamentally?
AbbVie Inc. has ROE of N/A vs HCA Healthcare, Inc.'s N/A. Net margins are 6.9% vs 9.0% respectively.
Which stock pays higher dividends, ABBV or HCA?
ABBV has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or HCA for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while HCA has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs HCA, the AI consensus favors HCA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.